Searched for
MERCK SHARP
Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata MotorsIndian markets saw volatility and closed lower on Wednesday. Key companies are in focus due to significant developments. SoftBank reduced i...- Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
- Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Aurobindo Pharma arm extends negotiations deadline with MSD for contract manufacturing operationsAurobindo Pharma extends deadline for CuraTeQ Biologics and Merck Sharp & Dohme Singapore negotiations on contract manufacturing operations...
- Sun Pharma says gearing up to launch COVID drug molnupiravirThe company said the Drugs Controller General of India (DCGI) is currently reviewing clinical data of molnupiravir for the treatment of COV...
- Gland Pharma gets tentative nod from USFDA for generic Sugammadex injectionThe company "has received tentative approval from the United States Food and Drug Administration (USFDA) for Sugammadex injection, 200 mg/2...
- Five local companies to start trials of Covid drugMerck or Merck Sharpe Dohme (MSD), the innovator, has already issued a voluntary licence to these companies to manufacture and supply Molnu...
- MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufactur...
- Lupin launches Posaconazole delayed-release tabletsIn a regulatory filing, Lupin Ltd announced launch of Posaconazole delayed-release tablets, 100 mg, after its alliance partner AET Pharma U...
- Unichem Labs gets USFDA nod for asthma drugThe tablets are indicated for prophylaxis and chronic treatment of asthma in adults and pediatric patients - 12 months of age and older.
- Unichem gets USFDA nod for hypertension treatment tabletsThe product is generic version of Merck Sharp & Dohme Corp's Cozaar tablets in the strength of 25 mg, 50 mg and 100 mg, Unichem said.
- Glenmark Pharma falls 5% intraday after court injunction on two drugsGlenmark slipped 5% in trade on Monday, after Delhi high court restrained the company from manufacturing and marketing anti-diabetes drug.
- MSD-Glenmark drug patent row: Delhi High Court reserves verdictThe Delhi High Court today reserved its verdict on US drug major Merck Sharp and Dohme's appeal against a single judge bench order.
- Americans won’t go against Indian pharma because of Ranbaxy deeds: Kevin Ali, Merck Sharp & Dohme"The creative feel about this country is unlike any other I have in my regions, which includes pretty much the whole world, excluding the U...
- No interim relief to Merck against Glenmark’s diabetes genericsDelhi High Court has refused to bar Glenmark from selling the generic versions of anti-diabetic drugs manufactured by Merck Sharp & Dohme.
- Patent row: Delhi High Court refuses interim relief to US drug firm MerckThe court's order came on MSD's plea alleging that the Indian pharma company has violated its intellectual property right (IPR) over its an...
- Patent row: Delhi High Court refuses interim relief to US drug firm MerckThe development assumes significance as on Monday the Supreme Court had rejected the plea of Novartis AG for patent protection of its anti-...
- Stocks to watch: HCL Tech, SBI, Mahindra Satyam, Adani Enterprises, Jindal Steel and PowerIndia's fifth-largest IT services company HCL Technologies on Tuesday bagged a $500-million strategic IT outsourcing contract from the US-b...
Load More
